title: [Usefulness of determining tumor markers CEA, CA125 and CA72-4 in blood serum of patients with ovarian carcinoma].
abstract: Serum levels of 3 markers: CEA, CA125 and CA72-4 have been determined in 58 patients aged from 15-60 years with histologically diagnosed ovarian cancer. Serum CEA was determined by radioimmunoassay using kits POLATOM (Poland), CA72-4 was determined using kits CIS BIOINTERNATIONAL (France) and CA125 was determined by enzyme immunoassay using kits Hoffmann-la-Roche (Wien-Austria). We have observed the growth of sensitivity and specificity of serum levels: CA125 and CA72-4 if we have referred to the simultaneous elevation of CA125 and CA72-4 markers. We have observed that CA125 and CA72-4 elevated levels were proceeded clinical recurrent of the disease from 2 to 6 months.
authors.affiliation: Katedry i Kliniki Chirurgii Ogólnej Slaskiej Akademii Medycznej w Katowicach.
authors.forename: D
authors.initials: D
authors.lastname: Kokocińska
authors.forename: J
authors.initials: J
authors.lastname: Worwag
authors.forename: J
authors.initials: J
authors.lastname: Tomala
authors.forename: L
authors.initials: L
authors.lastname: Dzieciuchowicz
authors.forename: S
authors.initials: S
authors.lastname: Nowak
authors.forename: S
authors.initials: S
authors.lastname: Kuśmierski
mesh_terms: D000293:Adolescent; D000328:Adult; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000097:blood*; D018394:CA-125 Antigen / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D002277:Carcinoma / Q000097:blood; D004407:Dysgerminoma / Q000097:blood; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000097:blood*; D010051:Ovarian Neoplasms / Q000097:blood*; D011863:Radioimmunoassay; D012680:Sensitivity and Specificity; D013724:Teratoma / Q000097:blood
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D018394:CA-125 Antigen; C083825:CA-72-4 antigen; D002272:Carcinoembryonic Antigen
vernacular_title: Przydatność oznaczeń markerów nowotworowych CEA, CA125 i CA72-4 w surowicy krwi chorych na raka jajnika.